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ABSTRACT 38 
 39 
The use of nutritional supplements to improve sporting performance and increase training 40 
adaptations is commonplace amongst athletes and is an expanding market in terms of product 41 
choice and availability. The purpose of this study was to examine the effects of two ergogenic 42 
aids with extracellular blood buffering potential, namely sodium bicarbonate (NaHCO3) and a 43 
lactate supplement, during a 40 km cycling time trial. Seven recreationally active males (age, 44 
22.3 ± 3.3 years; height, 182.5 ± 6.5 cm; body mass, 79.2 ± 6.3 kg) completed five 40 km 45 
cycling time trials, including a familiarization trial in a randomized blind double placebo 46 
design. Subjects ingested either (a) 300 mg per kg body mass NaHCO3 (BICARB), (b) 45 mg 47 
per kg sodium chloride (PL-BICARB) as the placebo for the NaHCO3 trial, (c) 1115 mg 48 
lactate (LACTATE), or (d) plain flour as the placebo for the lactate trial (PL-LACTATE) 60 49 
minutes before exercise. There was no significant difference in performance between the four 50 
conditions (p > 0.05). Whilst NaHCO3 ingestion induced significant changes in all the acid-51 
base variables (all p < 0.05), no significant change was seen following lactate ingestion (p > 52 
0.05). Subjects in the LACTATE condition did have a significantly higher heart rate (p < 53 
0.05) without experiencing any greater perceived exertion (p > 0.05) than the other three 54 
conditions. Neither NaHCO3 nor lactate supplementation appear to improve 40 km cycling 55 
time trial performance. However the potential benefits following LACTATE regarding 56 
perceived exertion require further research. 57 
 58 
Key Words: buffering, alkalosis, ergogenic aid, NaHCO3, acid-base 59 
 60 
  
INTRODUCTION 61 
 62 
The use of nutritional ergogenic supplements are commonplace within sport as both 63 
recreational and professional athletes aim to improve performance and increase training 64 
adaptations(19). Previous research into the benefits of induced metabolic alkalosis on both 65 
prolonged continuous and intermittent high-intensity exercise has proved to be equivocal(22). 66 
The majority of research has found no significant improvement in endurance performance 67 
following induced alkalosis in cycling(1, 32, 36). The exception to these however was 68 
McNaughton, Dalton and Palmer(21) who reported a 14% increase in work capacity during 69 
60 minutes of high-intensity cycling following the ingestion of sodium bicarbonate 70 
(NaHCO3). If the results from such fixed time duration studies could be replicated in a more 71 
practical setting such as time trial cycling involving set distance, then NaHCO3 could prove 72 
to be an inexpensive ergogenic aid. A negative side effect of NaHCO3 however is the 73 
possibility of gastrointestinal (GI) distress(6, 34) which ultimately may offset any possible 74 
positive benefits to be gained.      75 
 76 
Decreases in intramuscular pH have previously been reported to inhibit the contractile 77 
processes by either a) restricting myofilament function through reducing Ca
2+
 sensitivity(7, 78 
11)
 
or b) effecting the excitation-contraction process relating to the uptake and release of Ca
2+
 79 
by the sarcoplasmic reticulum(16, 33). By ingesting NaHCO3 prior to exercise, extracellular 80 
bicarbonate (HCO3
-
) reserves are supplemented, resulting in an increased plasma pH and an 81 
induced state of metabolic alkalosis(30). The extracellular to intracellular pH gradient 82 
therefore increases as HCO3
-
 is impermeable to cellular membranes(22) resulting in a greater 83 
efflux of H
+
 and lactate from active muscles(26). This occurs via either simple diffusion or by 84 
  
the lactate/H
+
 co-transporters(17) and has been demonstrated by the higher lactate 85 
concentrations post-exercise following NaHCO3 ingestion(1, 28). Increases in plasma HCO3
-
 86 
have also been reported following the ingestion of lactate with no reported GI distress(24, 87 
39), showing potential for it to be utilized as an alternative exogenous buffer to NaHCO3.  88 
 89 
Within exercise metabolism the role of lactate and in particular its production, has been a 90 
source of much dispute(4, 11, 15). Debate remains whether the presence of lactate acts as a 91 
limiting factor during exercise by inducing acidosis or actually attenuates the onset of fatigue 92 
by consuming the excess H
+
 responsible for acidosis(4). Many of the studies associating 93 
lactate with the development of fatigue tend to be based upon correlational data(4) therefore a 94 
cause and effect relationship cannot be ascertained. Furthermore, lactate has the potential to 95 
serve as a source of glucose generated from within the body as a substrate for 96 
gluconeogenesis(3). Based upon the lactate shuttle theory(2), exogenous lactate 97 
supplementation therefore has the potential to increase plasma glucose supplied via 98 
gluconeogenesis thus sparing glycogen stores
20
. However to date, research(3, 27, 38) has 99 
failed to support this theory. 100 
  101 
The purpose of this study therefore was to determine whether either NaHCO3 or lactate 102 
supplementation had any ergogenic potential to improve 40 km time trial performance. 103 
Additionally it was designed to establish whether any improvement in performance was 104 
associated with changes in acid-base status and buffering capacity. It was hypothesized that 105 
the use of either NaHCO3 or a lactate supplement would improve the performance of a 40 km 106 
cycling time trial. Furthermore, it was hypothesized that lactate supplementation would 107 
  
increase both plasma lactate levels and buffering capacity whilst causing less GI distress than 108 
is associated with NaHCO3 consumption. 109 
 110 
METHODS 111 
 112 
EXPERIMENTAL APPROACH TO THE PROBLEM 113 
 114 
Using a randomized, double placebo-controlled design; subjects were required to complete a 115 
total of five trials, one familiarization trial and four experimental trials. Subjects were 116 
instructed to arrive for testing in a rested state having refrained from strenuous exercise and 117 
alcohol in the 24 hour prior to testing and had no history of either NaHCO3 or lactate 118 
supplementation. Subjects were asked to ingest a minimum of 500 ml of water before 119 
arriving at the laboratory to ensure they arrived in a well hydrated state, avoiding caffeine in 120 
the 12 hours prior to each trial. They were also asked to consume the same standardized 121 
breakfast a minimum of 1 hour prior to arriving for each trial. Subjects performed each of the 122 
five trials at the same time of day to control for circadian variation in performance(9). 123 
Additionally, each trial was separated by a period of 6 to 9 days in order to ensure an 124 
adequate recovery period was attained whilst limiting the opportunity for any improvement 125 
being the result of training. 126 
 127 
The four experimental conditions were (a) 300 mg per kg body mass NaHCO3 (BICARB), 128 
(b) 45 mg per kg sodium chloride (PL-BICARB) as the placebo for the NaHCO3 trial, (c) 129 
  
1115 mg lactate from a combination of calcium lactate pentahydrate and magnesium lactate 130 
dihydrate, equivalent to a mean of 14.1 mg.kg
-1
 body mass per participant based on mean 131 
body weight (Sport Specifics, Inc., Chagrin Falls, OH, USA) (LACTATE), and  (d) plain 132 
flour as the placebo for the lactate trial (PL-LACTATE). All supplements were ingested 133 
within gelatine capsules with 500 ml low calorie cordial over a 10 minute period, 60 minutes 134 
prior to exercise. Due to the disparity between the NaHCO3 and lactate trials in terms of 135 
capsules required, a double placebo design was chosen to improve validity. The use of 300 136 
mg per kg body mass NaHCO3 has been established as the optimal dose for enhanced 137 
buffering capacity(22) and has previously been used in a number of studies into NaHCO3 138 
supplementation(5, 25, 33). Furthermore, peak HCO3
-
 levels are typically achieved 60 139 
minutes following ingestion(34). The lactate supplement dosage used was as per the 140 
manufacturer’s instructions. It was felt that this dosage of the supplement should be chosen as 141 
consumers who purchase this supplement are unlikely to exceed the recommended dosage.   142 
 143 
In terms of performance, the dependent variables of interest were overall performance time, 144 
split performance time, heart rate and rate of perceived exertion (RPE). For changes in acid-145 
base status the dependent variables were pH, base excess (BE), HCO3, lactate and H
+
.  146 
Changes in overall performance time represent an accurate comparison between trials whilst 147 
ultimately being the key variable of interest for competitive cyclists. The use of split times 148 
allowed for changes during individual stages to also be identified. The use of pH, BE, HCO3 149 
and H
+
 in research looking at changes in buffering capacity following supplementation is 150 
well established (5, 34, 35). Furthermore, as one of the supplements contained exogenous 151 
lactate, it was important to establish whether any changes in plasma lactate occurred 152 
following its ingestion. 153 
  
 154 
SUBJECTS 155 
 156 
Seven recreationally active non-smoking male subjects (mean ± SD: age, 22.3 ± 3.3 years; 157 
height, 182.5 ± 6.5 cm; body mass, 79.2 ± 6.3 kg) with no previous history of supplementing 158 
their diets with ergogenic agents volunteered to participate in this study. The subjects 159 
consisted of four cyclists, two footballers and a long distance runner, all whom were in a 160 
period of regular training at the time of testing. They were all completing a minimum of four 161 
hours (6.3 ± 3.3 hours) training per week and all were free from any known cardiac or 162 
metabolic diseases. All subjects provided written informed consent, and the study was 163 
approved by the Departmental Human Ethics Committee and following the principles 164 
outlined in the Declaration of Helsinki. 165 
 166 
PROCEDURES 167 
 168 
On arrival at the laboratory, the subject had a capillary blood sample taken to establish basal 169 
acid-base measurements (pH, BE, HCO3
-
, lactate and H
+
) before ingesting the relevant 170 
supplement. During the 60 minute post-ingestion period, further capillary blood samples were 171 
taken at 10, 20, 30, 45 and 60 minutes post ingestion to evaluate any induced changes in the 172 
acid-base variables. All blood samples were collected using 100 μl balanced heparin blood 173 
capillary tubes (Radiometer, West Sussex, UK) and immediately analyzed (Radiometer, 174 
ABL800, Copenhagen, Denmark). 175 
  
  176 
During the ingestion period, subjects were asked to rate any GI discomfort experienced every 177 
15 minutes using a visual analogue scale (VAS) until the exercise commenced.  The potential 178 
symptoms listed were: nausea, flatulence, stomach cramping, stomach bloating, stomach-179 
ache, belching, vomiting, bowel urgency and diarrhoea. The VAS scale consisted of nine 180 
separate 100 mm scales, anchored at each end with either ‘no symptom’ or ‘severe symptom’ 181 
and subjects indicated with a vertical mark the severity of each symptom during the ingestion 182 
period(5, 34). None of the subjects reported any instances of GI disturbance during the 60 183 
minute pre-exercise period as a result of ingesting BICARB, LACTATE or either placebo. 184 
 185 
Following the 60 minute post ingestion capillary blood sample, the subject completed a ten 186 
minute warm up at an intensity of 75 watts prior to beginning the 40 km time trial. The time 187 
trial was conducted using a Wattbike cycle ergometer (Wattbike Ltd, Nottingham, UK) with 188 
heart rate (Polar FS1 HRM, Polar Electro, OY, Finland) and rate of perceived exertion (RPE) 189 
recorded at five minute intervals. RPE was monitored using a modified version of Foster et 190 
al.(12) perceived exertion scale. Subjects were permitted to drink water ad libitum. During 191 
each trial, subjects were blinded to all performance data except the distance countdown. The 192 
purpose for this was to minimize any learning effect to be gained from previous trials. 193 
Additional capillary blood samples were collected at 20 km, 40 km and at 15 minutes post-194 
exercise.  195 
 196 
STATISTICAL ANALYSES 197 
 198 
  
Statistical analyses were completed using IBM PASW statistics 18 (SPSS inc., Chicago, Il). 199 
Central tendency and dispersion of all data are displayed as mean ± standard deviation (S.D). 200 
Performance time data was compared using a one way analysis of variance (ANOVA) with 201 
repeated measures whilst changes in acid-base status, heart rate and RPE were investigated 202 
using two way ANOVA with repeated measures. Sidak-adjusted p values were used for 203 
subsequent pairwise comparisons to establish the significant paired differences when 204 
significant F ratios were found by the respective ANOVA. Statistical significance was 205 
accepted as p < 0.05 with effect size reported according to partial eta squared.  206 
 207 
RESULTS 208 
 209 
PERFORMANCE DATA 210 
 211 
The mean times for 10 km, 20 km, 30 km and 40 km along with the individual split times for 212 
each 10 km interval are displayed in Table 1. Whilst overall performance time for LACTATE 213 
was between 1-3% faster than the other three conditions, the difference was not significant (p 214 
>0.05, ƞp
2
 = 0.20). Furthermore, the individual split times for each 10 km stage of the time 215 
trial were not significantly different between the four conditions (p >0.05). Individual 216 
responses to the supplements were varied with 3 subjects performing their fastest trial in the 217 
LACTATE condition, whilst 2 performed fastest in PL-LACTATE, and 1 subject completing 218 
the time trial fastest in each of the BICARB and PL-BICARB conditions (Figure 1).  219 
 220 
  
INSERT TABLE 1 221 
 222 
INSERT FIGURE 1 223 
 224 
Average heart rate during the LACTATE condition (169 ± 9 bpm) was significantly higher 225 
than in the other three conditions (BICARB: 160 ± 16 bpm; PL-BICARB: 158 ± 13 bpm; PL-226 
LACTATE: 160 ± 14 bpm respectively; p < 0.05, ƞp
2
 = 0.49) throughout the duration of the 227 
time trials. No significant difference was seen however between the other three conditions. 228 
Both heart rate and RPE (both p <0.05, ƞp
2
 = 0.71 and ƞp
2
 = 0.85 respectively) was seen to 229 
increase progressively with each 10 km stage of the time trial (Table 2). No significant main 230 
effect for condition or interaction effect between condition and stage (both p >0.05, ƞp
2
 = 231 
0.18 and ƞp
2
 = 0.11 respectively) was seen for RPE between the four conditions.  232 
 233 
INSERT TABLE 2 234 
 235 
ACID-BASE BALANCE 236 
 237 
Changes in pH, BE, HCO3
-
, lactate and H
+
 for the four conditions across the study are 238 
displayed in Table 3. There was no significant difference between pre-ingestion levels for any 239 
of the blood variables between the four conditions. During the BICARB condition, blood pH 240 
was significantly higher at 45 and 60 minutes post ingestion than seen at pre-ingestion (p < 241 
0.05, ƞp
2
 = 0.84), whilst H
+
 levels were significantly lower at the same time points (p < 0.05, 242 
  
ƞp
2
 = 0.67). By 60 minutes post-BICARB ingestion, BE had increased by in excess of 5 243 
mEq/L (p < 0.05, ƞp
2
 = 0.85) and plasma HCO3
-
 by approximately 4.5 mmol/L compared to 244 
the pre-ingestion levels (p < 0.05, ƞp
2
 = 0.84) and significantly increased compared to 245 
LACTATE, PL-BICARB & PL-LACTATE (all p < 0.05) at the same time point. No 246 
significant differences were seen within the other three experimental conditions during the 247 
pre-ingestion to 60 minute post-ingestion period. Furthermore, no significant difference were 248 
seen for lactate concentration between pre-ingestion and 60 minutes post-ingestion (p >0.05, 249 
ƞp
2
 = 0.11) for any of the four conditions. 250 
 251 
INSERT TABLE 3 252 
 253 
After 20 km and 40 km, pH, BE and HCO3
-
 remained elevated and H
+
 was lower for the 254 
BICARB condition compared to the other three conditions (Table 3). All the differences 255 
between the BICARB condition and the other three conditions were significant except for pH 256 
and H
+
 at 40 km compared to PL-LACTATE (both p >0.05) and BE at 40 km compared to 257 
the LACTATE condition (p >0.05). Whilst at the end of the time trial, plasma lactate was 258 
between 2-3 mmol/L higher for the BICARB condition, the difference was only significant 259 
compared to PL-LACTATE (p < 0.05, ƞp
2
 = 0.48). No significant difference was seen for 260 
lactate between the LACTATE, PL-LACTATE and PL-BICARB. 261 
 262 
DISCUSSION 263 
 264 
  
Whilst mean performance time following the ingestion of the lactate supplement was over 30 265 
seconds faster than the next nearest condition (Table 1) the performance effect was not 266 
significant. This mean difference was influenced by subject 2 whose individual time during 267 
the supplement trial was around 3 minutes faster than the other three conditions (Figure 1). 268 
Additionally ingestion NaHCO3 did not provide any significant ergogenic effect on 40 km 269 
time trial performance. Using the same lactate supplement, Peveler and Palmer(27)
 
also 270 
found no significant effect on performance of 20 km time trial cycling, heart rate or mean 271 
power with the lactate condition actually marginally slower than placebo by ~17.4 seconds on 272 
average. They did however fail to show the individual performance times for each condition 273 
making it difficult to establish if there was an individual specific response from any of their 274 
subjects. Additionally, other forms of lactate supplementation focusing on lactate as a 275 
gluconeogenic precursor for endurance exercise have also been previously used 276 
unsuccessfully. Both Bryner et al.(3) and Swensen et al.(38) combined lactate and 277 
carbohydrate to examine its effect on time to exhaustion (TTE).  Bryner et al.(3) found no 278 
significant effect on either TTE or peak power using a protocol that involved cycling at 10 279 
beats below target heart rate and ended with a Wingate power test during the last 30 seconds 280 
of the trial. Swensen et al.(38) also found no effect on TTE between when cycling at 70% 281 
VO2max until exhaustion. 282 
 283 
Whilst the current study also supports the majority of research
 
in finding that NaHCO3 did 284 
not improve prolonged exercise performance(1, 28, 36) one exception remains(21). 285 
McNaughton et al.(21) reported an increase in both overall work (in kilojoules) and average 286 
power following the ingestion of NaHCO3 over a 60 minute period of maximal cycling. In 287 
this study the 40-km time trial was chosen as it represented a similar duration to that seen in 288 
  
McNaughton et al.(21) however the use of a set distance as opposed to set time duration 289 
provided a greater reflection of competitive cycling.  290 
 291 
The increase in buffering capacity achieved by ingesting NaHCO3 prior to exercise has 292 
previously been well documented(6, 22, 35) although the benefits are typically associated 293 
with events lasting between 30 seconds to 3 minutes(22, 30, 34). Lactate levels during the 294 
current study were higher following NaHCO3 ingestion than that of the other three conditions 295 
at both 20 km and 40 km although only to a significant level at 40 km over PL-LACTATE 296 
(Table 3). It has been suggested that by increasing extracellular levels of HCO3
-
, the efflux of 297 
lactate and H
+
 from within the muscle is facilitated(13, 21) with similar results having 298 
previously been found by Price et al.(28). In theory this could have improved performance by 299 
maintaining pH closer to the homeostatic levels(21). McNaughton et al.(21) attributed their 300 
significant increase in work during their 60 minute cycling study to the maintenance of pH 301 
nearer to resting levels allowing greater contractile performance. Interestingly though, 302 
McNaughton et al.(21) also reported plasma lactate levels lower than those of their control 303 
(no supplement) and placebo (sodium chloride) trials. Whilst conflicting with the expected 304 
higher lactate levels seen in the current study, a difference in protocol may account for the 305 
disparity between studies. 306 
 307 
Despite the improved acid-base status prior to and during exercise following NaHCO3 308 
ingestion in the current study, the lack of improvement in performance would appear to 309 
indicate an alternative factor separate from acidosis was the predominant cause of fatigue. 310 
Although using an alternative buffer in the form of sodium citrate, Schabort et al.(32) 311 
supported this as during the trial with the highest pH, lactate concentrations were not the 312 
  
highest showing other factors contributed to the fatigue. Whilst allowing the subjects to 313 
consume the same standardized breakfast before each trial was intended to attenuate the 314 
effect of glycogen depletion on fatigue its effects cannot be ruled out. Furthermore the 315 
accumulation of inorganic phosphate rather than H
+  
has also been associated with restricting 316 
the contractile processes(40) however as these were not measured in the current study, its role 317 
cannot be determined.  318 
 319 
Lactate supplementation has also been suggested as an alternative acid-base buffer to 320 
NaHCO3(24) however the results from this study fail to support this. Previous research has 321 
reported increases in plasma HCO3
-
 following lactate ingestion(10, 24, 39) however a lack of 322 
reported pre-ingestion HCO3
-
 levels mean that the level of increase is difficult to 323 
quantifiy(10, 39). Morris et al.(24) reported increases in plasma HCO3
-
 levels of 324 
approximately 3 mmol/L between pre-ingestion levels and 80 minutes post-ingestion. In the 325 
present study, four of the seven subjects experienced an increase in HCO3
-
 following 326 
ingestion of the lactate supplement although the largest increase seen was just 1 mmol/L 327 
between pre-ingestion and 60 minutes post ingestion compared to an average increase of 4.6 328 
mmol/L for the NaHCO3 condition. However, the concentration of lactate supplement in this 329 
study was considerably less than the 120 mg/kg body mass of lactate used by Morris et 330 
al.(24) or the 320 mg/kg body mass of lactate used by Van Montfoort et al.(39). The reduced 331 
dosage in the current study was used as it followed the manufacturers’ guidelines and is 332 
similar to that previously used by Peveler and Palmer(27).  333 
 334 
In the current study, the expected increase in plasma lactate failed to be observed following 335 
the ingestion of the lactate supplement. The lactate shuttle theory by which exogenous lactate 336 
  
supplementation is thought to increase gluconeogenesis and improve performance however is 337 
highly disputed(27). An increase in plasma lactate is thought to promote increased plasma 338 
lactate oxidation whilst inhibiting intramuscular lactate production(14). Miller et al.(23) 339 
regulated lactate plasma levels to 4 mmol/L during exercise of moderate intensity via 340 
intravenous infusion. As a result of this, the contribution of glycogenolysis in supplying 341 
plasma glucose decreased as increased lactate oxidation compensated potentially sparing 342 
glycogen stores. However, in the current study an increase in plasma lactate levels was not 343 
observed following ingestion. Neither Morris et al.(24) nor Van Montfoort et al.(39)
 
reported 344 
significant increases in plasma lactate despite using considerably larger quantities of lactate. 345 
Whilst a change in the rate of lactate oxidation potentially may account for a rise in plasma 346 
lactate not being shown, other explanations may exist. It is possible that the oral consumption 347 
of lactate was either too small to elicit a change or it failed to increase the lactate availability 348 
due to degradation by stomach acid and/or lack of absorption, unlike the direct intravenous 349 
method used by Miller et al.(23). 350 
.  351 
Given athletes are likely to follow manufacturers recommendations when using 352 
supplementations due to safety and overall cost issues(27), both the small change in acid-base 353 
status and the absence of an increase in plasma lactate following lactate supplementation, 354 
suggests the dosage used does not represent a viable alternative to NaHCO3 for increasing 355 
buffering capacity. The use of a chronic dosing of lactate over a number of days may be an 356 
option in the future as it has been previously shown to increase acid-base status when using 357 
NaHCO3(8, 20). However, given the negligible increases in acid-base status in this current 358 
study, each individual dose would possibly need to be increased from current study for any 359 
effect to be seen. Future investigations into alternative dosing strategies are therefore 360 
warranted 361 
  
 362 
An increase in RPE over time was observed but this was not different between conditions 363 
(Table 2). However average heart rate was higher during the LACTATE condition compared 364 
to the other three conditions. Although performance differences were not significant overall 365 
in this group, the increased heart rate during the LACTATE condition may therefore have 366 
contributed for the faster performance time, although heart rate measurements were only 367 
recorded every 5 minutes meaning heart rate for each 10 km stage is based on a total of two 368 
or three measurements, which may have affected the results gained. Whilst the increased 369 
heart rate in the LACTATE condition occurred without altering perceived exertion, the 370 
subjective nature of RPE measure makes it difficult to conclude if the difference was related 371 
to the supplement. In a similar study, Peveler and Palmer(27) reported reduced RPE 372 
following the ingestion of a lactate supplement although this may have been accounted for by 373 
the slower performance time compared to the placebo condition. The effect of induced 374 
alkalosis upon the RPE following NaHCO3 and lactate ingestion has been equivocal to date 375 
with both positive(18, 31, 37) and negative(13) effects reported.  This variety in results 376 
however can probably be accounted for by the variety of different exercise protocols, 377 
ingestion strategies and subject training statuses used throughout the previous literature(10, 378 
13, 18, 31, 37).  379 
 380 
PRACTICAL APPLICATIONS 381 
 382 
The pursuit of legal ergogenic aids continues at both a recreational and professional level(21). 383 
Whilst the majority of NaHCO3 supplementation research has focused on either single or 384 
  
multiple bouts of short duration maximal intensity exercise(22, 30, 34), the research 385 
conducted into prolonged continuous and intermittent exercise has proved equivocal(1, 21, 386 
28). The current study has demonstrated there is little ergogenic benefit to be gained by 387 
inducing metabolic alkalosis via NaHCO3 supplementation prior to prolonged cycling. 388 
Although not significant the LACTATE condition was fastest for three of the seven subjects 389 
and was on average approximately 30 seconds faster than the nearest condition. Whilst this 390 
figure was influenced by an individual performance of around 3 minutes faster during the 391 
lactate than the other three conditions, it raises the possibility that the ergogenic effect is 392 
individual specific. Considering the tight winning margins typically associated with time trial 393 
competition, any legal supplement that could provide such performance gains obviously 394 
would prove beneficial.  395 
 396 
Using the dosages seen in the current study, lactate supplementation did not offer a viable 397 
alternative to NaHCO3 in terms of improving blood buffering capacity. However, given 398 
NaHCO3 ingestion is associated with GI distress(5, 6, 34)
 
which may reduce any ergogenic 399 
benefits that may be achieved(34), research into alternative buffering agents is warranted.  In 400 
this study no GI distress for either supplement was reported, suggesting that lactate 401 
supplementation is not associated with GI distress at this concentration and that the response 402 
to NaHCO3 is individual specific, as recently alluded to by Price and Simons(29). Future 403 
work on lactate supplementation should therefore focus of dosing strategies in order to 404 
maximize the potential for an ergogenic effect to be seen on performance. Given any 405 
ergogenic effect of lactate supplementation appears to be individual specific, experimentation 406 
of the supplement prior to prolonged use is essential to assess the cost-benefit analysis to the 407 
individual. 408 
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FIGURES 
 
 
Figure 1.  Individual performance times for each of the four experimental conditions 
BICARB = Sodium Bicarbonate; LACTATE = Lactate supplement; PL-BICARB = Sodium 
Chloride; PL-LACTATE = Flour 
 
 
 
 
 
 
 
 
 
  
 
TABLES 
Table 1. Mean 40 km Cycling time trial performance times (minutes) including split times for the four 
experimental conditions (mean ± S.D) (n=7) 
 
Split times displayed in brackets 
BICARB = Sodium Bicarbonate; LACTATE = Lactate supplement; PL-BICARB = Sodium Chloride; 
PL-LACTATE = Flour 
 
 
 
 
 
 
 10 km 20 km 30 km 40 km 
BICARB 
 
17.07 ± 1.45 34.06 ± 3.15 
(17.00 ± 1.32) 
50.56 ± 4.29  
(16.50 ± 1.15) 
67.08 ± 5.04 
(16.11 ± 1.00) 
 
LACTATE 
 
16.19 ± 1.14 32.55 ± 2.26 
(16.36 ± 1.15) 
49.47 ± 3.40 
(16.52 ± 1.16) 
66.02 ± 4.44 
(16.15 ± 1.06) 
 
PL-BICARB 
 
16.48 ± 1.21 33.31 ± 2.24 
(16.55 ± 1.12) 
50.41 ± 3.23 
(16.59 ± 1.09) 
66.41 ± 4.04 
(15.59 ± 0.50)  
 
PL-LACTATE 
 
16.57 ± 1.38 
 
33.55 ± 2.59 
(16.58 ± 1.27) 
51.05 ± 4.02 
(17.10 ± 1.08) 
67.54 ± 5.34 
(16.49 ± 1.53) 
  
Table 2. Mean heart rate and rate of perceived exertion for the four conditions during each 10 km 
stage of the time trial (mean ± S.D) (n=7) 
 Stage (km) 
 0-10 km 10-20 km 20-30 km 30-40 km 
Heart rate* (BPM)     
BICARB 149.3 ± 17.6 157.0 ± 15.0 161.4 ± 13.8 170.3 ± 10.6 
LACTATE 162.9 ± 9.5 169.3 ± 6.1 169.7 ± 6.3 176.1 ± 4.3 
PL-BICARB 150.9 ± 11.1 155.6 ± 10.5 158.7 ± 12.9 168.0 ± 12.7 
PL-LACTATE 152.6 ± 17.6 158.0 ± 13.8 162.7 ± 10.1 168.7 ± 8.1 
 
RPE*     
BICARB 4.4 ± 1.1 5.0 ± 1.0 5.8 ± 0.7 6.7 ± 0.8 
LAC TATE 4.7 ± 0.5 5.5 ± 0.9 6.1 ± 1.2 7.6 ± 1.2 
PL-BICARB 4.9 ± 1.3 5.6 ± 1.2 6.1 ± 0.5 7.3 ± 1.1 
PL-LACTATE 3.9 ± 1.3 4.7 ± 0.9 5.5 ± 0.9 7.1 ± 0.9 
 
*Significant main effect for stage, p < 0.05; BICARB = Sodium Bicarbonate; LACTATE = Lactate 
supplement; PL-BICARB = Sodium Chloride; PL-LACTATE = Flour 
  
Table 3 Mean acid-base variables at different time points pre- and post- ingestion for the four conditions (mean ± S.D) (n=7) 
 
  Pre-
ingestion 
10 min 
post- 
ingestion 
20 min 
post-
ingestion 
30 min 
post-
ingestion 
45 min 
post-
ingestion 
60 min 
post-
ingestion 
20 km 40 km 15 min 
post-
exercise 
pH BICARB 
7.402 7.416 7.418 7.433 7.443*
+
 7.450**
++ 
7.446*° 7.385° 7.460* 
 LACTATE 
7.399 7.403 7.401 7.402 7.398 7.399 7.366 7.332 7.388 
 PL-BICARB 
7.397 7.396 7.405 7.404 7.411 7.392 7.374 7.312 7.375 
 PL-LACTATE 
7.406 7.400 7.398 7.398 7.397 7.393 7.381 7.333 7.377 
           
BE BICARB 
0.2 1.0 2.6 3.6 4.6*
+ 
5.7**
++
 1.3* -3.9
# 
2.3** 
(mEq/L) LACTATE 
0.6 0.7 1.0 0.9 0.7 0.7 -6.0 -9.0 -3.5 
  
 PL-BICARB 
1.0 0.5 0.8 0.5 0.8 0.6 -4.6 -9.2 -4.4 
 PL-LACTATE 
0.6 0.3 0.2 0.6 0.7 0.7 -4.3 -7.7 -3.2 
           
HCO3  BICARB 
24.6 25.3 26.4 27.4 28.3*
+ 
29.2**
++ 
26.0**
++ 
21.6*
 
26.7** 
(mmol/L) LACTATE 
24.8 24.9 25.1 25.0 24.8 24.8 20.0 17.8 21.8 
 PL-BICARB 
25.0 24.7 25.0 24.8 25.1 24.7 20.9 17.4 21.1 
 PL-LACTATE 
24.8 24.6 24.5 24.8 24.7 24.7 21.3 18.6 22.0 
           
H
+ 
BICARB 
39.7 38.4 38.3 36.9 36.0* 35.5** 35.9** 41.4
#
 34.6* 
(mmol/L) LACTATE 
39.9 39.6 39.7 39.7 40.0 40.0 43.1 46.6 41.0 
  
 PL-BICARB 
40.1 40.2 39.4 39.5 38.9 40.5 42.4 48.8 42.2 
 PL-LACTATE 
39.3 39.8 40.0 40.0 40.1 40.5 41.8 46.5 41.6 
           
La BICARB 
2.2 1.9 2.0 1.9 1.8 1.6 8.6 12.8
^ 
7.5 
(mmol/L) LACTATE 
1.9 2.1 1.7 1.8 1.7 1.8 7.8 10.7 5.3 
 PL-BICARB 
1.8 1.8 1.7 1.8 1.6 1.6 6.6 10.6 5.4 
 PL-LACTATE 
1.6 1.7 1.8 1.6 1.7 1.7 6.9 9.7 5.0 
           
 
BICARB = Sodium Bicarbonate; LACTATE = Lactate supplement; PL-BICARB = Sodium Chloride; PL-LACTATE = Flour; BE = Base excess; HCO3 = 
Bicarbonate; H
+
 = Hydrogen ion; La = Lactate 
  
*Significant difference between BICARB  and LACTATE/PL-BICARB/PL-LACTATE,  p < 0.05, **Significant difference between BICARB and 
LACTATE/PL-BICARB/PL-LACTATE, p < 0.01, ° Significant difference between BICARB  and LACTATE/PL-BICARB,  p < 0.05, 
# 
Significant 
difference between BICARB  and PL-BICARB/PL-LACTATE,  p < 0.05, 
^ 
Significant difference between BICARB  and PL-LACTATE,  p < 0.05, 
+
 
Significantly different to pre-ingestion levels, p < 0.05, 
++
 Significantly different to pre-ingestion levels, p < 0.01.
  
 
